Haemonetics (HAE) Tops Q1 EPS by 1c, provides guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.92 +0.07%
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $336.17 million versus the consensus estimate of $335.05 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.60.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
